174 related articles for article (PubMed ID: 33897103)
1. Culture media optimization for Chinese hamster ovary cell growth and expression of recombinant varicella-zoster virus glycoprotein E.
Kim KS; Park SA; Wui SR; Ko A; Lee NG
Cytotechnology; 2021 Jun; 73(3):433-445. PubMed ID: 33897103
[TBL] [Abstract][Full Text] [Related]
2. Efficient induction of cell-mediated immunity to varicella-zoster virus glycoprotein E co-lyophilized with a cationic liposome-based adjuvant in mice.
Wui SR; Kim KS; Ryu JI; Ko A; Do HTT; Lee YJ; Kim HJ; Lim SJ; Park SA; Cho YJ; Kim CG; Lee NG
Vaccine; 2019 Apr; 37(15):2131-2141. PubMed ID: 30827737
[TBL] [Abstract][Full Text] [Related]
3. Enhanced Potency and Persistence of Immunity to Varicella-Zoster Virus Glycoprotein E in Mice by Addition of a Novel BC02 Compound Adjuvant.
Li J; Fu L; Yang Y; Wang G; Zhao A
Vaccines (Basel); 2022 Mar; 10(4):. PubMed ID: 35455278
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of glycoprotein E subunit and live attenuated varicella-zoster virus vaccines formulated with a single-strand RNA-based adjuvant.
Lee SJ; Park HJ; Ko HL; Lee JE; Lee HJ; Kim H; Nam JH
Immun Inflamm Dis; 2020 Jun; 8(2):216-227. PubMed ID: 32167678
[TBL] [Abstract][Full Text] [Related]
5. Recombinant Glycoprotein E of Varicella Zoster Virus Contains Glycan-Peptide Motifs That Modulate B Cell Epitopes into Discrete Immunological Signatures.
Nordén R; Nilsson J; Samuelsson E; Risinger C; Sihlbom C; Blixt O; Larson G; Olofsson S; Bergström T
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30813247
[TBL] [Abstract][Full Text] [Related]
6. Baculovirus Display of Varicella-Zoster Virus Glycoprotein E Induces Robust Humoral and Cellular Immune Responses in Mice.
Xue W; Li T; Zhang S; Wang Y; Hong M; Cui L; Wang H; Zhang Y; Chen T; Zhu R; Chen Z; Zhou L; Zhang R; Cheng T; Zheng Q; Zhang J; Gu Y; Xia N; Li S
Viruses; 2022 Aug; 14(8):. PubMed ID: 36016407
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity in Mice Immunized with Recombinant Adenoviruses Expressing Varicella-Zoster Virus Envelope Glycoprotein E.
Zheng Y; Huang L; Ding H; Xu H; Shu R; Yu J; Peng X; Fu Y; He J
Viruses; 2023 Nov; 15(12):. PubMed ID: 38140528
[TBL] [Abstract][Full Text] [Related]
8. Recombinant glycoprotein E produced in mammalian cells in large-scale as an antigen for varicella-zoster-virus serology.
Thomsson E; Persson L; Grahn A; Snäll J; Ekblad M; Brunhage E; Svensson F; Jern C; Hansson GC; Bäckström M; Bergström T
J Virol Methods; 2011 Jul; 175(1):53-9. PubMed ID: 21540058
[TBL] [Abstract][Full Text] [Related]
9. Herpes Zoster Vaccines.
Harbecke R; Cohen JI; Oxman MN
J Infect Dis; 2021 Sep; 224(12 Suppl 2):S429-S442. PubMed ID: 34590136
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity of Varicella Zoster Virus DNA Vaccines Encoding Glycoprotein E and Immediate Early Protein 63 in Mice.
Liu J; Lin J; Cai L; Sun J; Ding X; Wang C; Wu Y; Gao X; Su W; Jiang C
Viruses; 2022 Jun; 14(6):. PubMed ID: 35746685
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity generated by mRNA vaccine encoding VZV gE antigen is comparable to adjuvanted subunit vaccine and better than live attenuated vaccine in nonhuman primates.
Monslow MA; Elbashir S; Sullivan NL; Thiriot DS; Ahl P; Smith J; Miller E; Cook J; Cosmi S; Thoryk E; Citron M; Thambi N; Shaw C; Hazuda D; Vora KA
Vaccine; 2020 Aug; 38(36):5793-5802. PubMed ID: 32703745
[TBL] [Abstract][Full Text] [Related]
12. Herpes Zoster and Immunogenicity and Safety of Zoster Vaccines in Transplant Patients: A Narrative Review of the Literature.
Wang L; Verschuuren EAM; van Leer-Buter CC; Bakker SJL; de Joode AAE; Westra J; Bos NA
Front Immunol; 2018; 9():1632. PubMed ID: 30079064
[TBL] [Abstract][Full Text] [Related]
13. A novel nonlive, adjuvanted herpes zoster subunit vaccine: a report on the emerging clinical data and safety profile.
Brosio F; Masetti G; Matteo G; Stefanati A; Gabutti G
Infect Drug Resist; 2018; 11():1401-1411. PubMed ID: 30233219
[TBL] [Abstract][Full Text] [Related]
14. Baculovirus Vector-Based Varicella-Zoster Virus Vaccine as a Promising Alternative with Enhanced Safety and Therapeutic Functions.
Lee C; Kim M; Chun J; Kim S; Yoon D; Lee H; Bang H; Lee HJ; Park H; Kim YB
Vaccines (Basel); 2024 Mar; 12(3):. PubMed ID: 38543967
[TBL] [Abstract][Full Text] [Related]
15. Purification, characterization and immunogenicity of recombinant varicella-zoster virus glycoprotein gE secreted by Chinese hamster ovary cells.
Haumont M; Jacquet A; Massaer M; Deleersnyder V; Mazzu P; Bollen A; Jacobs P
Virus Res; 1996 Feb; 40(2):199-204. PubMed ID: 8725116
[TBL] [Abstract][Full Text] [Related]
16. The herpes zoster subunit vaccine.
Cunningham AL
Expert Opin Biol Ther; 2016; 16(2):265-71. PubMed ID: 26865048
[TBL] [Abstract][Full Text] [Related]
17. Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention.
Lecrenier N; Beukelaers P; Colindres R; Curran D; De Kesel C; De Saegher JP; Didierlaurent AM; Ledent EY; Mols JF; Mrkvan T; Normand-Bayle M; Oostvogels L; Da Silva FT; Vassilev V; Vinals C; Brecx A
Expert Rev Vaccines; 2018 Jul; 17(7):619-634. PubMed ID: 30028651
[TBL] [Abstract][Full Text] [Related]
18. [Herpes Zoster Vaccine].
Watanabe D
Uirusu; 2018; 68(1):21-30. PubMed ID: 31105132
[TBL] [Abstract][Full Text] [Related]
19. Development of an Indirect ELISA Kit for Rapid Detection of Varicella-Zoster Virus Antibody by Glycoprotein E.
Niu Y; Wang A; Zhou J; Liu H; Chen Y; Ding P; Qi Y; Liang C; Zhu X; Zhang G
Front Microbiol; 2022; 13():897752. PubMed ID: 35572642
[TBL] [Abstract][Full Text] [Related]
20. Vaccine profile of herpes zoster (HZ/su) subunit vaccine.
Cunningham AL; Heineman T
Expert Rev Vaccines; 2017 Jul; 16(7):1-10. PubMed ID: 28486850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
